Mechanism of cardioprotective action of TNF-α in the isolated rat heart

Experimental and Clinical Cardiology

Volumn 7, Issue 2-3, 2002, Pages 146-150

  Rathi, Satyajeet S ^a,b   Xu, Yan Jun ^a,b   Dhalla, Naranjan S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adult cardiomyocytes; Cardiac function; Intracellular calcium; Ischemia reperfusion; Tumour necrosis factor

Indexed keywords

CALCIUM; FURA 2; POTASSIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL TISSUE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CARDIOVASCULAR EFFECT; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; HEART FUNCTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART WORK; HEMODYNAMIC PARAMETERS; IN VIVO STUDY; INHIBITION KINETICS; ISOLATED HEART; MALE; NONHUMAN; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

EID: 0036768363     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Nakano M, Knowlton AA, Dibbs Z, Mann DL. Tumor necrosis factor-α confers resistance to hypoxic injury in adult mammalian cardiac myocytes. Circulation 1998;97:1392-400.
2. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995;96:1042-52.
3. Bader T, Wietzerbin J. Nuclear accumulation of interferon gamma. Proc Natl Acad Sci USA 1994;91:11831-5.
4. Giror BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992;90:693-8.
5. Hammond GL, Wieben E, Markert CL. Molecular signals for initiating protein synthesis in organ hypertrophy. Proc Natl Acad Sci USA 1979;76:2455-9.
6. Das KC, Lewis-Molock Y, White CW. Activation of NF-kappa B and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am J Physiol 1995;269:L588-602.
7. Weiss T, Grell M, Hessabi B, et al. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: Requirement of the TNF receptor-associated factor-2 binding site. J Immunol 1997;158:2398-404.
8. Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA 1996;93:6721-5.
9. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997;95:1247-52.
10. Bozkurt B, Kribbs SB, Clubb FJ Jr, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97:1382-91.
11. Kurrelmeyer KM, Michael LH, Baumgarten G, et al. Endogenous tumor necrosis factor protect the adult cardiac myocytes against ischemic-induced apoptosis in murine model of acute myocardial infarction. Proc Natl Acad Sci USA 2000;97:5456-61.
12. Eddy LJ, Goeddel DV, Wong GHW. Tumor necrosis factor-α pre-treatment is protective in a rat model of myocardial ischemia reperfusion injury. Biochem Biophys Res Commun 1992;184:1056-9.
13. Nelson SK, Wong GHW, McCord JM. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol 1995;27:223-9.
14. Yamashita N, Hoshida S, Otsu K, Taniguchi N, Kuzuya T, Hori M. Involvement of cytokines in the mechanism of whole-body hyperthermia-induced cardioprotection. Circulation 2001;102:452-7.
15. Meldrum DR, Dinarello CA, Shames BD, et al. Ischemic preconditioning decreases post ischemic myocardial tumor necrosis factor-α production. Potential ultimate effect mechanism of preconditioning. Circulation 1998;98(19 Suppl):II214-9.
16. Mann DL, Young JB. Basic mechanism in congestive heart failure recognizing the role of the proinflammatory cytokines. Chest 1994;105:897-904.
17. 2+ and cardiac contractile force. Am J Physiol 1996;271:H651-9.
18. Kashiwagi A, Nishio Y, Saeki Y, Kida Y, Kodama M, Shigeta Y. Plasma membrane specific deficiency in cardiac β-adrenergic receptor in streptozotocin induced diabetic rats. Am J Physiol 1989;257:E127-32.
19. 2+ to phosphatidic acid in chronic diabetes. Can J Cardiol 1996;12:1092-8.
20. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993;92:2303-12.
21. Murry DR, Freeman GL. Tumor necrosis factor-α produces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996;78:154-60.
22. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BC, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
23. Tracey KJ, Butler B, Lowery SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-4.
24. Natanson CP, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs stimulate in cardiovascular profile of human septic shock. J Exp Med 1989;169:823-32.
25. Maury CPJ, Teppo AM. Circulating tumor necrosis factor-α (cachectin) in myocardial infarction. J Intern Med 1989;225:333-6.
26. Lefer AM, Tsao P, Aoki N, Pallandino MA Jr. Mediation of cardioprotection by transforming growth factor-α. Science 1990;249:61-4.
27. Smith SC, Allen PM. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 1992;70:856-63.
28. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
29. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;223:236-41.
30. Pagani FD, Baker LS, Hsi C, Knox MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 1992;90:389-98.
31. Eichenholz PW, Eichacker PQ, Hoffman WD, et al. Tumor necrosis factor challenges in canine: Patterns of cardiovascular dysfunction. Am J Physiol 1992;263:H668-75.
32. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol Reg Integ Comp Physiol 1998;274:R577-95.
33. Dollery CM, McEwan JR, Hennery AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:763-8.
34. Lohi J, Keski-Oja J. Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kD gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 1995;270:17602-9.
35. Gottaschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995;64:1513-20.
36. Galis ZS, Muszynski M, Sukova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-9.
37. Brown JM, Anderson BO, Repine JE, et al. Neutrophils contribute to TNF induced tolerance to ischemia. J Mol Cell Cardiol 1992;24:185-95.
38. Dhalla NS, Panagia V, Singal PK, Makino N, Dixon IMC, Eyolfson DA. Alteration in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 1988;116:3-9.
39. Low-Friedrich I, Wiesensee D, Mitorou P, Schoeppe W. Cytokines induce stress protein formation in cultured cardiac myocytes. Basic Res Cardiol 1992;87:12-8.
40. Nakano M, Knowlton AA, Yokoyama T, Lesslauer W, Mann DL. Tumor necrosis factor-α induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am J Physiol 1996;270:H1231-9.
41. Knowlton AA. The role of heat shock proteins in the heart. J Mol Cell Cardiol 1995;27:121-31.